1998
Cost and Cost-Effectiveness of Increasing Access to Sterile Syringes and Needles as an HIV Prevention Intervention in the United States
Holtgrave D, Pinkerton S, Jones T, Lurie P, Vlahov D. Cost and Cost-Effectiveness of Increasing Access to Sterile Syringes and Needles as an HIV Prevention Intervention in the United States. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s133-s138. PMID: 9663636, DOI: 10.1097/00042560-199802001-00022.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV infectionHIV prevention interventionsSterile syringesPrevention interventionsIDUs' accessActive injection drug usersIllicit drug injectionPublic health decision makersSyringe exchange programsHealth decision makersHIV transmissionDrug injectionHIV preventionHypothetical cohortDrug usersMedical carePocket expenditureInfectionPharmacy salesProgram coverageLifetime costsHigh levelsSyringesUnited States
1996
Evidence for HIV Type 1 Strains of U.S. Intravenous Drug Users as Founders of AIDS Epidemic among Intravenous Drug Users in Northern Europe
Lukashov V, Kuiken C, Vlahov D, Coutinho R, Goudsmit J. Evidence for HIV Type 1 Strains of U.S. Intravenous Drug Users as Founders of AIDS Epidemic among Intravenous Drug Users in Northern Europe. AIDS Research And Human Retroviruses 1996, 12: 1179-1183. PMID: 8844022, DOI: 10.1089/aid.1996.12.1179.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHomosexual menDrug usersV3 sequencesEuropean intravenous drug usersHIV Type 1 StrainsAIDS epidemicHIV-1 epidemicGp120 V3 loopSignature pattern analysisType 1 strainsRisk groupsV3 loopEpidemiological linkMenEpidemicVirusUnited StatesSuggestive evidencePresent suggestive evidenceHigh levelsNucleotide substitutionsEuropean origin